Kelly Zhang is a Senior Fellow and Director at Genentech. She leads analytical R&D teams on both drug substance and drug formulation. She has over 20 years of pharmaceutical industry experience at Genentech, Allergan and Pfizer. She has published over 80 peer-reviewed papers in the field of pharmaceutical analysis, covering synthetic molecules, biologic conjugates and nucleic acid based medicines. She is a member of the Permanent Scientific Committee of the International HPLC Conferences and the International Pharmaceutical and Biomedical Analysis Conference.
Kelly Zhang is a Senior Fellow and Director at Genentech. Photo Credit: © Kelly Zhang.
Kelly was interviewed at ISC 2024 by LCGC international and answered the following questions related to analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.